1st 10 months of 2021 saw a record Rs. 74000 crores raised through IPO’s By end of 2021, its expected that around 1 Lac crores to be raised through IPO 3 of the 4 largest IPO’s were from loss-making Consumer – tech companies Similar IPO frenzy was 1st seen during 1995, when Jan-95 saw 145…More
Snapshot of Sept 21 Quarterly Results
Snapshot of Sept 21 Quarterly Results. India Inc has given an extraordinary performance.More
Nifty View 22 Nov 21
Consolidation is getting stronger week by week Gone week Bulls couldn’t do much & bears were in action, though on Monday Bulls started strong , then rest of days been badly beaten by Bears. On downside Nifty may not go below 1st Gap(17550-17576)-1st Support or in worse case 17350. This consolidation going to stretch little…More
Ready reckoner of FD, Small Savings, Home Loan, Insurance – 21 Nov 21
A concise ready reckoner of: Banks & Company FD rates Bond yields, Small Savings & Home Loan interest rates Term Insurance premium tracker Top PMS schemes Source: BusinessLine Portfolio – 21.11.2021More
Reliance-Aramco deal stands cancelled
Reliance-Aramco deal stands cancelled, RIL to withdraw demerger application of O2C businessMore
Global Inflation rates
Laurus Labs Charts suggest buying near marked levels
LaurusLabs made low of 452.3( 450 expected) and now taking resistance from trendline. Techincal charts suggest buying near marked levels for a time horizon of 2-3yrs.More
Precursor to LIC IPO – Policy holders quota introduced for IPO
Policyholder Quota is introduced in IPOs.More
Tata Elxsi – Can witness pullback or a long consolidation to cool off the RSI
Tata Elxsi Monthly chart Has broken out of the long term channel but the RSI at 94 is just too high for comfort. This stock can witness a healthy pullback or a long consolidation to cool off the RSI before starting it’s next moveMore
Why did Laurus Labs buy a stake in a startup ImmunoACT?
Laurus Labs bought a significant minority stake (26.62%) in a cell and gene therapy startup Immuno ACT Biologics is a high gestation and high investment area within the Pharma industry Typical development times range in many years and take about 5+ years on average to really scale up and transition to commercial production This also…More
My Investment Notes 